Norwegian Organization for Quality Improvement of Laboratory Examinations (Noklus), 72982 Haraldsplass Deaconess Hospital , Bergen, Norway.
Department of Medical Biochemistry and Pharmacology, The Norwegian Porphyria Centre, Haukeland University Hospital, Bergen, Norway.
Clin Chem Lab Med. 2024 Mar 20;62(8):1483-1489. doi: 10.1515/cclm-2024-0108. Print 2024 Jul 26.
Analytical performance specifications (APS) are typically established through one of three models: (i) outcome studies, (ii) biological variation (BV), or (iii) state-of-the-art. Presently, The APS can, for most measurands that have a stable concentration, be based on BV. BV based APS, defined for imprecision, bias, total allowable error and allowable measurement uncertainty, are applied to many different processes in the laboratory. When calculating APS, it is important to consider the different APS formulae, for what setting they are to be applied and if they are suitable for the intended purpose. In this opinion paper, we elucidate the background, limitations, strengths, and potential intended applications of the different BV based APS formulas. When using BV data to set APS, it is important to consider that all formulae are contingent on accurate and relevant BV estimates. During the last decade, efficient procedures have been established to obtain reliable BV estimates that are presented in the EFLM biological variation database. The database publishes detailed BV data for numerous measurands, global BV estimates derived from meta-analysis of quality-assured studies of similar study design and automatic calculation of BV based APS.
分析性能规格(APS)通常通过以下三种模型之一来建立:(i)结果研究,(ii)生物变异(BV),或(iii)最新技术。目前,对于大多数浓度稳定的测定物,APS 可以基于 BV。基于 BV 的 APS,定义为精密度、偏差、总允许误差和允许测量不确定度,适用于实验室中的许多不同过程。在计算 APS 时,重要的是要考虑不同的 APS 公式,它们适用于什么设置,以及它们是否适合预期用途。在本意见书中,我们阐明了基于 BV 的不同 APS 公式的背景、局限性、优势和潜在应用。当使用 BV 数据来设置 APS 时,重要的是要考虑到所有公式都取决于准确和相关的 BV 估计。在过去的十年中,已经建立了有效的程序来获得可靠的 BV 估计值,这些估计值在 EFLM 生物变异数据库中公布。该数据库为众多测定物发布了详细的 BV 数据,以及从类似研究设计的经过质量保证研究的荟萃分析中得出的全球 BV 估计值,以及基于 BV 的 APS 的自动计算。